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Background. Diagnosis of malaria relies on parasite detection by microscopy or antigen detection; both fail to
detect low-density infections. New tests providing rapid, sensitive diagnosis with minimal need for training would
enhance both malaria diagnosis and malaria control activities. We determined the diagnostic accuracy of a new
loop-mediated ampliﬁcation (LAMP) kit in febrile returned travelers.
Methods. The kit was evaluated in sequential blood samples from returned travelers sent for pathogen testing
to a specialist parasitology laboratory. Microscopy was performed, and then malaria LAMP was performed using
Plasmodium genus and Plasmodium falciparum–speciﬁc tests in parallel. Nested polymerase chain reaction (PCR)
was performed on all samples as the reference standard. Primary outcome measures for diagnostic accuracy were
sensitivity and speciﬁcity of LAMP results, compared with those of nested PCR.
Results. A total of 705 samples were tested in the primary analysis. Sensitivity and speciﬁcity were 98.4% and
98.1%, respectively, for the LAMP P. falciparum primers and 97.0% and 99.2%, respectively, for the Plasmodium
genus primers. Post hoc repeat PCR analysis of all 15 tests with discrepant results resolved 4 results in favor of
LAMP, suggesting that the primary analysis had underestimated diagnostic accuracy.
Conclusions. Malaria LAMP had a diagnostic accuracy similar to that of nested PCR, with a greatly reduced
time to result, and was superior to expert microscopy.
Keywords. malaria; diagnostics; LAMP.
Since the 1880s, the standard diagnostic test for
malaria has been microscopic examination of periph-
eral blood smears [1–3]. The development of rapid
antigen-detection tests (RDTs) in the early 1990s has
improved diagnosis of Plasmodium infection inmalaria-
endemic countries and targeting of treatment [4, 5].
In countries where malaria is not endemic, where im-
ported malaria cases in travelers can be mistaken for
nonspeciﬁc viral illness [6, 7], causing delay in diagno-
sis and in some cases progression to severe illness and
death [8–11], RDTs have improved the capacity for
rapid malaria diagnosis by nonspecialist health workers
[12–15]. While RDTs and expert microscopy are con-
sidered adequate for case management in malaria-
endemic populations [16], there is growing interest in
“improvements in point-of-care tests for case manage-
ment, and the development of new tests capable of
identifying very low parasite densities in asymptomatic
individuals in ﬁeld settings for mass screening and
treatment” [17].
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Polymerase chain reaction (PCR), in its most sensitive form,
has a limit of detection as low as 50 parasites per milliliter of
peripheral blood [18, 19], although results take 10–16 hours,
whereas expert microscopy is less sensitive but routinely pro-
duces results in 60 minutes. Real-time quantitative PCR
(qPCR) can reliably detect parasite DNA within 3–5 hours of
sample receipt but is also less sensitive than nested PCR [20].
Recent studies show that loop-mediated ampliﬁcation (LAMP)
assays for malaria, which deploy isothermal molecular ampliﬁ-
cation in a closed system with visual readout, can deliver PCR-
level diagnostic accuracy in a little more than 1 hour, with
lower laboratory capacity requirements [21–23]. To date,
malaria LAMP has not been available in a format suited to
routine diagnosis in the clinic. A clinically validated, CE-
marked assay would be an attractive alternative to RDT and mi-
croscopy in settings where malaria is or is not endemic.
A malaria LAMP kit has been developed as a point-of-care di-
agnostic test, and after CE marking it was released commercially
in mid-2012. This kit comprises a disposable extraction device
and tubes containing vacuum-dried and temperature-stable reac-
tion components. We investigated the diagnostic accuracy of this
kit for case management in a study of sequential blood samples
from suspected imported malaria cases received by a specialist
parasitology laboratory in London, United Kingdom, over the
ﬁrst 7 months of 2011. Primary diagnosis was by expert micro-
scopic examination of blood ﬁlms. An established nested PCR
assay was deployed as the reference standard [18]. Diagnostic ac-
curacy of the new kit was superior to that of microscopy and
similar to that of nested PCR but with the additional beneﬁts of
reduced assay time and ease of operation.
METHODS
Patients and Samples
The study was conducted according to a detailed protocol that
conforms to the STARD (Standards for the Reporting of Diag-
nostic Accuracy Studies) guidelines [24]. A synopsis of the pro-
tocol was considered and approved as service improvement
activity by the United Kingdom National Research Ethics
Service. No patient information was retained other than that
routinely collected, and individual patient identiﬁers were
removed from the study database. Clinical staff retained the
ability to link study data to patient records.
The target sample size was 866 blood samples (Supplementa-
ry Materials). All samples sent for blood parasite testing in the
Department of Clinical Parasitology, Hospital of Tropical Dis-
eases, London, between 24 January and 20 July 2011 that origi-
nated from either the walk-in clinic, inpatient wards, or the
Accident and Emergency Department in the main hospital
were eligible for inclusion in the study. Venous blood for malaria
diagnosis was collected in anticoagulant tubes containing either
ethylenediaminetetraacetic acid (EDTA; for microscopy and
nested PCR) or heparin (for the malaria LAMP test). An aliquot
of the EDTA blood sample was sent to the University College
London Hospital Haematology Department for white blood cell
(WBC) counting.
Diagnostic microscopy was performed as per routine stan-
dard operating procedures for malaria diagnosis. Each day, a
member of staff not involved in performing the malaria LAMP
test assigned each heparin blood sample a unique study sample
identiﬁer in a predeﬁned random order. A single study re-
searcher performed all the malaria LAMP assays; this individu-
al received the anonymous samples and thus was blinded to all
microscopy results.
An aliquot of each EDTA blood sample (200 µL) was stored
at −20°C for later extraction of DNA for nested PCR. DNAwas
prepared in batches of 12 samples, using an automated system
as previously described [20]. Parasite density was estimated for
positive samples by counting the number of parasites present
per 500 WBCs and converting the sum to parasites per microli-
ter of blood, using the actual WBC count for that sample. A
ﬂuorescent probe–based qPCR was also used to estimate para-
site densities as previously described [20].
Malaria LAMP Assay
Heparinized blood samples were stored at 4°C until processing,
which typically occurred within 72 hours. DNA was puriﬁed
from whole blood using PURE extraction technology compris-
ing bespoke plastic ware, hardware, and reagents supplied by
Eiken Chemical ( Japan). Full details of kit contents and proce-
dures are provided online (available at: http://www.ﬁnddiag
nostics.org/programs/malaria-afs/lamp/standard_procedures/
index.html). A total of 35 µL of blood was aliquoted into a
heating tube containing extraction buffer. The tubes were
sealed with a screw-topped lid, shaken by hand, and incubated
in a dry block at 75°C for 5 minutes, after which they were
brieﬂy cooled. Tubes were then screwed into the top of the
PURE extraction tube, releasing the contents into clean-up
powder. Buffer and powder were mixed by vigorous shaking.
An injection cap supplied with the kit was screwed into the
base of the adsorbent tube, and 25 µL of puriﬁed DNA solution
was squeezed out of the tube, drop by drop, into the reaction
tubes. These were volumetrically marked during manufacturing
to allow 25 µL to be measured by eye.
Sealed reaction tubes were inverted brieﬂy to reconstitute the
reaction mixture vacuum-dried in the cap, including either pan–
Plasmodium genus or Plasmodium falciparum–speciﬁc primers,
before incubation at 65°C for 40 minutes in a real time LA-320
C turbidimeter (Eiken Chemical). Each set of patient samples
was run alongside a positive control (puriﬁed plasmid DNA)
and negative control (nuclease-free water) reaction. Upon termi-
nation of the reaction by incubation for 5 minutes at 85°C, the
tubes were removed from the turbidimeter. Two readers then in-
dependently scored reactions as positive or negative by eye, using
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a UV backlighting lamp (supplied with the LF-160 Simpliﬁed
LAMP Reactor, Eiken Chemical) to excite calcein ﬂuorescence
within the reaction mix. Individuals scoring the ﬂuorescence
assay were blinded to the results of the real-time turbidimetry
analysis. The real-time turbidity data were also recorded; this
was scored as positive if an increase in turbidity exceeding 0.1
OD units per second was observed.
For comparison with previously published studies, puriﬁed
DNAwas also prepared from heparin samples, using a boil and
spin method as described elsewhere [23]. The resultant super-
natant was diluted 1:12.5 with sterile H2O, 25 µL was trans-
ferred into a reaction tube containing either lyophilized
pan–Plasmodium genus or P. falciparum reagents, and then
tested and scored as described above.
Reference Assay
DNA was extracted from 200 µL aliquots of EDTA blood on an
automated platform (QiaCube, Qiagen, Germany) as described
elsewhere [19]. Five microliters of DNA extract was ampliﬁed
using nested PCR to detect P. falciparum, Plasmodium ovale
subspecies, Plasmodium vivax, and Plasmodium malariae
DNA, as per published methods [18, 23], following standard op-
erating procedures. Amplicons were visualized on 2% agarose
gels, independently scored by 2 investigators. Both individuals
were blinded to the microscopy and LAMP test results.
qPCR Estimation of P. falciparum Parasite Density
P. falciparum density was estimated from 2 µL of EDTA blood–
extracted DNA by qPCR as described elsewhere [20, 25]. All
other malaria species were recorded only as present or absent
by the qPCR assay.
Archive Sample Test Panel
An archive of anonymous samples from patients who presented
to the Hospital of Tropical Diseases between September 2008 and
January 2011, supplemented by 6 P. falciparum–infected and 17
P. vivax–infected blood specimens collected by the Instituto de
Medicina Tropical Alexander von Humbolt, Universidad Peruana
Cayetano de Heredia, Peru, as part of the specimen bank for the
World Health Organization Foundation for Innovative New Diag-
nostics RDT product testing program [14], was stored at −20°C.
From this collection, 20 parasite-negative, 10 P. ovale subspecies–
infected, 30 P. vivax–infected, 33 P. falciparum–infected, and 7
P. malariae–infected blood samples were randomly selected for
use in the LAMP study. An operator blinded to relevant parasito-
logical data processed these samples for LAMP-based and PCR-
based diagnosis as described above. LAMP results for these
samples were based solely on the real-time turbidimetry data.
Data Analysis
The unit of analysis was a single venous blood sample taken at
1 particular time. Some patients contributed multiple samples
at different times, each with a separate report form and
identiﬁer, but linkage to the primary sample was retained. Pa-
tients infected with P. falciparum were admitted for inpatient
care as recommended by United Kingdom guidelines [3], and
daily samples were taken until cure or discharge [7]. The fol-
lowing routine data collected by clinic staff were recorded:
sample date, date of birth, sex, history, fever history, and
current oral temperature. Because a number of samples came
from other hospital departments, travel history, fever history,
and current temperature were not always available. All data
were double entered by 2 team members into a password-pro-
tected Access database. The staff member performing LAMP
assays was not given access to the database, to maintain blind-
ing to microscopy and PCR data for each sample. After resolu-
tion of any entry discrepancies, the harmonized database was
duplicated and analyzed independently in parallel in London
and Geneva, following a previously agreed data analysis plan.
For each pairwise comparison between the index test (malaria
LAMP) and the reference (nested PCR), the null hypothesis of
no difference in performance between the 2 tests was retained
for P values of≥ .05, determined by the McNemar test. Conﬁ-
dence intervals (CIs) were calculated on the basis of the bino-
mial distribution (Clopper-Pearson).
Secondary analyses performed included comparison of
malaria LAMP and nested PCR results for a panel of previously
archived DNA extracted from patients with malaria and those
without malaria and exploratory PCR retesting, in triplicate, of
all samples for which the original PCR and malaria LAMP
results disagreed.
RESULTS
During the 6-month period of the study, 817 blood samples
were received for diagnostic microscopy. Of the blood samples
received, 707 comprised both EDTA and heparin collection
tubes; the majority of these were suspected malaria cases, but
there were also 12 requests to examine for Trypanosoma
species, 5 for Babesia species blood-stage parasites, and 1 for
Borrelia species. Microscopy, nested PCR, and malaria LAMP
tests were completed on 705 samples. Sample numbers and test
outcome summaries are presented as a ﬂow diagram in
Figure 1. A total of 330 of 664 individual patients (49.7%) con-
tributing samples were female. Mean age was 42.7 years (95%
CI, 41.1–44.3). Travel histories varied, often with multiple des-
tinations. The most prevalent single destinations were India
(104 journeys for 2 positive cases), Ghana (41 for 2 positive
cases), Nigeria (31 for 8 positive cases), Kenya (28 for 2 positive
cases), and Thailand (20 for no positive cases).
All 56 microscopy-positive samples were positive by both
PCR and LAMP. Of 648 microscopy-negative samples, 11 were
PCR positive for P. falciparum. Seven of these were posttreat-
ment follow-up samples from treated inpatients, 2 were from a
single individual who was microscopy negative on 2 different
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days 1 week apart but PCR positive on both occasions (and
was thus almost certainly carrying a persistent low-density par-
asitemia), and another was from an individual negative by mi-
croscopy but PCR positive (performed during the routine
diagnostic procedures for this sample). Detailed results for each
sample from each positive patient, together with parasite densities
estimated from both microscopy and qPCR, are presented in Sup-
plementary Table 1.
Primary Analysis of Test Diagnostic Accuracy
DNA templates prepared from blood by the boil and spin pro-
tocol performed in malaria LAMP with statistical equivalence
Figure 1. Flow chart of study. Results of all 3 tests deployed are summarized. Discrepancies between the gold standard and index tests are shown in
red boxes. Triplicate quality control (QC) repeats of the polymerase chain reaction (PCR) test from each sample with discrepant results, performed as a sec-
ondary analysis, resolved 4 of the 15 discrepancies. These were 3 PCR-negative, loop-mediated ampliﬁcation (LAMP)–positive discrepancies (1 of 9 Plas-
modium falciparum [Pf ] only, LAMP-positive samples and 2 of 3 Pf- and pan–Plasmodium genus [Pg]–positive samples), which were found to be PCR
positive in at least 1 of 3 QC replicates, and the single PCR-positive, LAMP-negative sample, which was found to be negative by PCR in all 3 QC replicates.
Abbreviation: EDTA, ethylenediaminetetraacetic acid.
Table 1. Diagnostic Accuracy of Malaria Loop-Mediated Ampliﬁcation (LAMP) as Compared to Gold Standard Nested Polymerase
Chain Reaction (PCR), and Blood Film Microscopy in 705 Sequential Malaria Tests
Comparison,
Primer Set
Sensitivity Specificity
PPV, % NPV, %
Percentage
(95% CI)
Subjects,
Proportiona
Percentage
(95% CI)
Subjects,
Proportionb
Malaria LAMP vs nested PCR
Pan–Plasmodium genus 97.0 (89.6–99.6) 65/67 99.2 (98.1–99.7) 633/638 92.7 99.7
P. falciparum 98.4 (91.5–100) 62/63 98.1 (96.8–99.0) 630/642 83.5 99.8
Microscopy vs nested PCR
Pan–Plasmodium genus 83.6 (72.5–91.5) 56/67 100 (99.4–100) 638/638 100 98.3
P. falciparum 82.5 (70.9–91.0) 52/63 100 (99.4–100) 642/642 100 98.3
Abbreviation: P. falciparum, Plasmodium falciparum.
a Data are no. of samples with positive results concordant with results of the gold standard/total no. of samples positive by gold standard.
b Data are no. of samples with negative results concordant with results of the gold standard/total no. of samples negative by gold standard.
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to templates prepared using the test extraction method (PURE)
for both primer sets (Supplementary Table 2). Therefore, for
comparison against the reference PCR, results using PURE ex-
traction of DNA and visual scoring of LAMP results are pre-
sented.
Malaria LAMP displayed diagnostic accuracy similar to that of
nested PCR and superior to that of expert microscopy. Table 1
presents sensitivity, speciﬁcity, negative predictive value, and posi-
tive predictive value for both LAMP tests as compared to nested
PCR. Comparison of microscopy with the reference standard is
also shown. In this analysis, the malaria LAMP with pan–
Plasmodium genus primers was statistically equivalent to PCR for
detection of all species (P = .257), whereas statistical nonequiva-
lence with PCR was found for detection of P. falciparum with
species-speciﬁc primers (P = .002). Microscopy displayed substan-
tially lower sensitivity than PCR and in head-to-head comparison
was found to be inferior to LAMP (P < .001, by the McNemar test,
for both pan–Plasmodium genus and P. falciparum primer sets).
Secondary Analysis—Archived Sample Bank
The malaria LAMP was also evaluated on an archived DNA
sample set (see Methods), generating high estimates for sensitiv-
ity and speciﬁcity that were similar to those obtained in the clini-
cal study (Table 2). A single sample from Peru found to harbor P.
vivax only by nested PCR tested for both P. falciparum and pan–
Plasmodium genus primers; this is presented as a LAMP false-
positive result for P. falciparum in Table 2 (but see Discussion).
Secondary Analysis—Nested PCR Post Hoc Quality Control
As shown in Figure 1, there was 100% concordance between
LAMP and nested PCR results for the 56 microscopy-positive
samples. However, there were 14 LAMP-positive samples that
tested negative by both microscopy and nested PCR and 1
sample that was PCR positive but negative by both LAMP and
microscopy. In a post hoc analysis, nested PCR was repeated in
triplicate for all 15 samples with discrepant results, along with
20 randomly selected samples from the study to act as controls,
by operators blinded to the original result. All 20 controls gave
the same result in triplicate repeat testing as that obtained in
the primary analysis. Of the 15 samples with discrepant results,
11 gave the same PCR result as that obtained in the primary
analysis. Three samples that were negative by the original
nested PCR but positive by LAMP were found to be positive in
at least 1 of the triplicate veriﬁcation tests. qPCR results sup-
ported these ﬁndings (Supplementary Table 1). We conclude
that these are true-positive results but with low parasite density,
suggesting a slightly higher sensitivity of malaria LAMP as
compared to the reference PCR assay. The single sample that
was positive by nested PCR in the primary analysis but negative
by LAMP tested negative in all nested PCR veriﬁcation test rep-
licates (9 PCR reactions in total). We conclude that this sample
had a false-positive nested PCR result in the primary analysis.
Factors Contributing to Discrepant Results Between the LAMP
Tests and the Gold Standard
There remained 11 blood samples in which a positive result
was obtained for either or both LAMP tests, but no parasite
DNA was detected by nested PCR. No evidence was found that
samples with discrepant results were more common in sub-
groups of samples deﬁned by parasite density, patient age, sex,
or WBC count (data not shown). We also tested for temporal
clustering of discrepant LAMP results. During a single 10-day
period from 13 to 22 June 2011, false ampliﬁcation in the nega-
tive control tube was observed in some LAMP tests. This had
been noted at the time, and simple remedial action was under-
taken in the forms of decontamination of the apparatus and
better separation between bench areas; false ampliﬁcation in
the negative control was then eliminated. We found that 5 of
the 11 samples (45.5%) with discrepant results were tested
during this period, compared with 6.4% of concordant samples
(odds ratio, 12.27; 95% CI, 2.82–49.96; P < .001, by the Fisher
exact test). This suggests transient laboratory contamination as
an extrinsic cause for these 5 discrepant results; problems with
the laboratory’s ventilation system had occurred during the
month of June.
DISCUSSION
The commercially manufactured malaria LAMP test evaluated
here, which ampliﬁes parasite mitochondrial gene targets,
Table 2. Malaria Loop-Mediated Ampliﬁcation (LAMP) Results
for 100 Archived Samples in Which Plasmodium Species Were
Detected by Gold Standard Nested Polymerase Chain Reaction
(PCR)
Nested PCR
Result
Samples,
No.
LAMP Result
P.
falciparum
Test
Positive
Pan–
Plasmodium
Genus Test
Positive
Agreement,
%
Negative 19 0 0 100
Positive
For P.
falciparum
33 33 33 100
For P.
falciparum
plus P. vivax
1 1 1 100
For P. malariae 7 0 7 100
For P. ovale 10 0 10 100
For P. vivax 30 1a 30 96.7
Overall 100 . . . . . . 99.0
Abbreviations: P. falciparum, Plasmodium falciparum; P. malariae, Plasmodium
malariae; P. ovale, Plasmodium ovale; P. vivax, Plasmodium vivax.
a Positive by both primer sets. It is plausible that this is a bona fide mixed
species infection with P. falciparummissed by PCR.
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demonstrated good diagnostic accuracy in comparison to the
reference nested PCR. Malaria LAMP demonstrated diagnostic
sensitivity signiﬁcantly superior to that of expert microscopy.
In the primary analysis, using pan–Plasmodium genus primers,
LAMP did not differ in performance from nested PCR
(P = .3447). LAMP with P. falciparum primers was found to
have signiﬁcantly different diagnostic accuracy than PCR
(P = .004), with a positive predictive value of 83.5% and a nega-
tive predictive value of 99.8%. Fifteen samples displayed dis-
crepant results between LAMP and PCR and were checked by
triplicate repeat testing with nested PCR. Four of these discrep-
ancies were thus resolved, conﬁrming the original LAMP result
as correct in each case. The remaining 11 samples with discrep-
ant results were all negative by PCR, suggesting false-positive
LAMP results. Five of these clustered in a single 10-day period
within the 6-month study, strongly suggesting a temporary
source of DNA contamination in the laboratory. Six apparent
false-positive LAMP results remain unexplained. This suggests
that, if deployed as the primary diagnostic test, the malaria
LAMP test would have correctly identiﬁed all 70 malaria infec-
tions and resulted in 11 false-positive results among the 638
uninfected samples. By use of a regret theory approach to deci-
sion making [26], and given the high sensitivity of the test, this
seems an acceptable type I error rate, as regret due to unneces-
sary treatment will be lower than that associated with untreated
Plasmodium infections. In fact, some apparent false-positive
discrepant results were resolved, by replicate PCR testing, in
favor of LAMP. Thus, the test format used here may be more
sensitive than the reference standard nested PCR. The design-
locked format tested here thus performs better than the proto-
type format previously described [23]. This notion cannot be
readily tested in the absence of a suitable tie-breaker test with a
sensitivity higher than that of nested PCR.
The current format of pan-Plasmodium genus and P.
falciparum–speciﬁc LAMP is able to identify all P. falciparum–
infected individuals. Nonfalciparum Plasmodium species are all
identiﬁed but not resolved to the species level (Table 2), a limi-
tation shared with most RDT tests. Among previously collected
positive blood samples, one sample characterized as P. vivax
monospecies infection by nested PCR was found to be positive
for P. falciparum by LAMP. This may be a bona ﬁde mixed
species infection, with P. falciparum being the minor species at a
density at or below the limit of detection for our nested PCR
assay: such cryptic mixed infections have been previously identi-
ﬁed in Peru, using PCR [27]. Additional species-speciﬁc primer
sets for P. malariae, P. ovale curtisi, P. ovale wallikeri, P. vivax,
and Plasmodium knowlesi may be useful developments for diag-
nosis of malaria in travelers returning from settings where these
species are prevalent. For patient management, however, the key
information for rapid decision making is whether malaria is
present and whether potentially fatal P. falciparum malaria is
present. The LAMP primer sets tested here are adequate in this
regard. Further species identiﬁcation is not required to inform
choice of chemotherapy for acute cases; when species identiﬁca-
tion is required, a PCR test performed afterward would sufﬁce.
The current test fulﬁlls requirements for use as a point-of-care
diagnostic test, namely a complete CE-marked sample processing
system using temperature-stable DNA-extraction reagents and
vacuum-dried reaction mixes contained within the reaction tubes.
This results in a simple, rapid test with minimal opportunity for
user error [28].We conclude that the current test format is a useful
diagnostic procedure for the case management of Plasmodium in-
fections. In the diagnostic laboratory of a developed country,
malaria LAMP provides a number of advantages over microscopy,
including superior sensitivity, minimal training requirements,
and signiﬁcantly less operator time. In the current study, a single
staff member routinely processed 14 patient samples to ﬁnal
result with both primer sets in 90 minutes. Simple facility and
equipment requirements, lower start-up costs, and greatly reduced
assay time are also signiﬁcant advantages over nested PCR, which
in our laboratory takes approximately 16 hours from sample
receipt to reporting, including 3–4 hours of operator time.
In malaria-endemic countries, low-cost point-of-care lateral
ﬂow tests are considered adequate for case management [16, 29].
However, the ability to test ﬁnger-stick blood samples with PCR-
equivalent diagnostic accuracy in a near-patient facility could
enable implementation of more cost-effective screening and
treatment strategies in low-transmission and elimination settings
[17, 30]. The costs of LAMP reagents are close to those used for
nested PCR, but comparison of both techniques in terms of
equipment and labor costs reveals that LAMP would be a more
affordable option for laboratories in malaria-endemic countries.
For similar reasons, the assay may have applications in antenatal
screening, drug-efﬁcacy monitoring (as an initial screening step),
and large-scale prevalence surveys, particularly if high-through-
put 96-well-plate formats can be developed [31, 32]. The accom-
panying article in this issue of the Journal that describes
deployment of the P. falciparum LAMP test at a rural clinic in
Tororo, Uganda, demonstrates the potential of LAMP for active
case detection in malaria-endemic countries [33].
In conclusion, the malaria LAMP test, evaluated here for the
primary diagnosis of malaria in returned travelers, has advan-
tages over other molecular tests in speed, sensitivity, and
minimal need for specialist training. Malaria LAMP is a suit-
able test for diagnosing imported cases of malaria in minimally
equipped clinical laboratories. The current test format has po-
tential to replace microscopy in developed country settings
and, because of the greater diagnostic accuracy provided,
reduce the delay to diagnosis of malaria in returned travelers.
Supplementary Data
Supplementary materials are available at The Journal of Infectious Diseases
online (http://jid.oxfordjournals.org/). Supplementary materials consist of
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data provided by the author that are published to beneﬁt the reader. The
posted materials are not copyedited. The contents of all supplementary data
are the sole responsibility of the authors. Questions or messages regarding
errors should be addressed to the author.
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